Global Respiratory Syncytial Virus Diagnostic Testing Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Respiratory Syncytial Virus Diagnostic Testing Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and breathing passages). It is a common cause of upper and lower respiratory infections in infants, young children, and elderly people. The infection can lead to severe complications such as pneumonia and bronchiolitis.
Respiratory Syncytial Virus Diagnostic Testing report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Respiratory Syncytial Virus Diagnostic Testing market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Diagnostic Laboratories are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Respiratory Syncytial Virus Diagnostic Testing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Respiratory Syncytial Virus Diagnostic Testing key companies include F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc. and Cepheid (Danaher Corporation), etc. F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific are top 3 players and held % share in total in 2022.
Respiratory Syncytial Virus Diagnostic Testing can be divided into Antigen Detection Test, Molecular Diagnostic Test, Direct Fluorescent Antibody Test and Diagnostic Imaging, etc. Antigen Detection Test is the mainstream product in the market, accounting for % share globally in 2022.
Respiratory Syncytial Virus Diagnostic Testing is widely used in various fields, such as Hospitals, Diagnostic Laboratories and Others,, etc. Hospitals provides greatest supports to the Respiratory Syncytial Virus Diagnostic Testing industry development. In 2022, global % share of Respiratory Syncytial Virus Diagnostic Testing went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Respiratory Syncytial Virus Diagnostic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
F. Hoffmann-La Roche AG
Abbott
Thermo Fisher Scientific
BD (Becton, Dickinson and Company)
QuidelOrtho Corporation
Hologic, Inc.
Luminex Corporation
Agilent Technologies, Inc.
Cepheid (Danaher Corporation)
DiaSorin S.p.A.
Segment by Type
Antigen Detection Test
Molecular Diagnostic Test
Direct Fluorescent Antibody Test
Diagnostic Imaging
Others
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Respiratory Syncytial Virus Diagnostic Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Respiratory Syncytial Virus Diagnostic Testing introduction, etc. Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Respiratory Syncytial Virus Diagnostic Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Respiratory Syncytial Virus Diagnostic Testing report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Respiratory Syncytial Virus Diagnostic Testing market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Diagnostic Laboratories are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Respiratory Syncytial Virus Diagnostic Testing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Respiratory Syncytial Virus Diagnostic Testing key companies include F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc. and Cepheid (Danaher Corporation), etc. F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific are top 3 players and held % share in total in 2022.
Respiratory Syncytial Virus Diagnostic Testing can be divided into Antigen Detection Test, Molecular Diagnostic Test, Direct Fluorescent Antibody Test and Diagnostic Imaging, etc. Antigen Detection Test is the mainstream product in the market, accounting for % share globally in 2022.
Respiratory Syncytial Virus Diagnostic Testing is widely used in various fields, such as Hospitals, Diagnostic Laboratories and Others,, etc. Hospitals provides greatest supports to the Respiratory Syncytial Virus Diagnostic Testing industry development. In 2022, global % share of Respiratory Syncytial Virus Diagnostic Testing went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Respiratory Syncytial Virus Diagnostic Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
F. Hoffmann-La Roche AG
Abbott
Thermo Fisher Scientific
BD (Becton, Dickinson and Company)
QuidelOrtho Corporation
Hologic, Inc.
Luminex Corporation
Agilent Technologies, Inc.
Cepheid (Danaher Corporation)
DiaSorin S.p.A.
Segment by Type
Antigen Detection Test
Molecular Diagnostic Test
Direct Fluorescent Antibody Test
Diagnostic Imaging
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Respiratory Syncytial Virus Diagnostic Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Respiratory Syncytial Virus Diagnostic Testing introduction, etc. Respiratory Syncytial Virus Diagnostic Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Respiratory Syncytial Virus Diagnostic Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices